Pharma Co. Shionogi Sues InterMune Over Drug Royalties

Law360, New York (July 10, 2012, 1:45 PM EDT) -- Japanese pharmaceutical company Shionogi & Co. Ltd. sued InterMune Inc. in California federal court on Thursday for allegedly bilking it out of royalties from sales of a lung disease treatment on which they partnered to win regulatory approval.

The controversy centers on a pact calling for the firms to share documents related to clinical trials each was conducting on the use of pirfenidone in idiopathic pulmonary fibrosis, a potentially fatal disorder involving scarred lung tissue.

California-based InterMune used Shionogi’s data to win European Medicines Agency approval...
To view the full article, register now.